Nomura Holdings’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,800
| Closed | -$310K | – | 899 |
|
|
2025
Q1 | $310K | Sell |
63,800
-130,800
| -67% | -$636K | ﹤0.01% | 905 |
|
|
2024
Q4 | $1.86M | Sell |
194,600
-63,900
| -25% | -$611K | ﹤0.01% | 632 |
|
|
2024
Q3 | $2.16M | Buy |
+258,500
| New | +$2.16M | 0.01% | 454 |
|
|
2021
Q3 | – | Sell |
-5,996
| Closed | -$378K | – | 1595 |
|
|
2021
Q2 | $378K | Buy |
5,996
+902
| +18% | +$56.9K | ﹤0.01% | 1128 |
|
|
2021
Q1 | $474K | Sell |
5,094
-244
| -5% | -$22.7K | ﹤0.01% | 1014 |
|
|
2020
Q4 | $478K | Buy |
5,338
+13
| +0.2% | +$1.16K | ﹤0.01% | 860 |
|
|
2020
Q3 | $550K | Buy |
+5,325
| New | +$550K | ﹤0.01% | 650 |
|
|
2016
Q4 | – | Sell |
-32,100
| Closed | -$998K | – | 1045 |
|
|
2016
Q3 | $998K | Buy |
32,100
+29,507
| +1,138% | +$917K | ﹤0.01% | 397 |
|
|
2016
Q2 | $78K | Buy |
2,593
+743
| +40% | +$22.4K | ﹤0.01% | 696 |
|
|
2016
Q1 | $67K | Sell |
1,850
-14,366
| -89% | -$520K | ﹤0.01% | 1039 |
|
|
2015
Q4 | $649K | Buy |
+16,216
| New | +$649K | ﹤0.01% | 556 |
|
|
2015
Q2 | – | Sell |
-9,695
| Closed | -$279K | – | 1460 |
|
|
2015
Q1 | $279K | Buy |
+9,695
| New | +$279K | ﹤0.01% | 1015 |
|
|
2014
Q2 | – | Sell |
-26,456
| Closed | -$664K | – | 1958 |
|
|
2014
Q1 | $664K | Buy |
26,456
+2,715
| +11% | +$68.1K | ﹤0.01% | 1029 |
|
|
2013
Q4 | $547K | Buy |
23,741
+844
| +4% | +$19.4K | ﹤0.01% | 1131 |
|
|
2013
Q3 | $435K | Buy |
+22,897
| New | +$435K | ﹤0.01% | 1368 |
|